Free Trial
NASDAQ:XXII

22nd Century Group (XXII) Stock Price, News & Analysis

22nd Century Group logo
$0.74 -0.09 (-10.60%)
As of 02:20 PM Eastern

About 22nd Century Group Stock (NASDAQ:XXII)

Key Stats

Today's Range
$0.70
$0.83
50-Day Range
$0.83
$3.43
52-Week Range
$0.74
$265.95
Volume
400,704 shs
Average Volume
373,995 shs
Market Capitalization
$1.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

22nd Century Group, Inc., a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands. The company was founded in 1998 and is headquartered in Mocksville, North Carolina.

Remove Ads

22nd Century Group Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
13th Percentile Overall Score

XXII MarketRank™: 

22nd Century Group scored higher than 13% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for 22nd Century Group.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of 22nd Century Group is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of 22nd Century Group is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about 22nd Century Group's valuation and earnings.
  • Percentage of Shares Shorted

    0.93% of the float of 22nd Century Group has been sold short.
  • Short Interest Ratio / Days to Cover

    22nd Century Group has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in 22nd Century Group has recently decreased by 70.79%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    22nd Century Group does not currently pay a dividend.

  • Dividend Growth

    22nd Century Group does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.93% of the float of 22nd Century Group has been sold short.
  • Short Interest Ratio / Days to Cover

    22nd Century Group has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in 22nd Century Group has recently decreased by 70.79%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    22nd Century Group has a news sentiment score of 0.21. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.80 average news sentiment score of Consumer Staples companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for 22nd Century Group this week, compared to 1 article on an average week.
  • Search Interest

    Only 5 people have searched for XXII on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    5 people have added 22nd Century Group to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, 22nd Century Group insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.10% of the stock of 22nd Century Group is held by insiders.

  • Percentage Held by Institutions

    Only 18.06% of the stock of 22nd Century Group is held by institutions.

  • Read more about 22nd Century Group's insider trading history.
Receive XXII Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 22nd Century Group and its competitors with MarketBeat's FREE daily newsletter.

XXII Stock News Headlines

22nd Century enters two new agreements for filtered cigar products
Now I look stupid. Real stupid...
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
22nd Century CEO, Chairman provides update letter
See More Headlines

XXII Stock Analysis - Frequently Asked Questions

22nd Century Group's stock was trading at $5.31 at the beginning of the year. Since then, XXII shares have decreased by 85.7% and is now trading at $0.76.
View the best growth stocks for 2025 here
.

22nd Century Group, Inc. (NASDAQ:XXII) announced its earnings results on Thursday, November, 4th. The biotechnology company reported ($31,104.00) earnings per share for the quarter, missing analysts' consensus estimates of ($20,736.00) by $10,368.00. The biotechnology company earned $7.81 million during the quarter, compared to analyst estimates of $8 million.

22nd Century Group shares reverse split on the morning of Tuesday, December 17th 2024. The 1-135 reverse split was announced on Friday, December 13th 2024. The number of shares owned by shareholders was adjusted after the market closes on Monday, December 16th 2024. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

Shares of XXII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that 22nd Century Group investors own include NVIDIA (NVDA), Meta Platforms (META), Canopy Growth (CGC), Advanced Micro Devices (AMD), Cara Therapeutics (CARA), Micron Technology (MU) and Novavax (NVAX).

Company Calendar

Last Earnings
11/04/2021
Today
4/16/2025
Next Earnings (Estimated)
5/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Cigarettes
Sub-Industry
Cannabis
Current Symbol
NASDAQ:XXII
Previous Symbol
AMEX:XXII
Employees
80
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-140,770,000.00
Net Margins
-144.09%
Pretax Margin
-120.10%

Debt

Sales & Book Value

Annual Sales
$11.88 million
Price / Cash Flow
N/A
Book Value
($417.78) per share
Price / Book
0.00

Miscellaneous

Free Float
1,715,000
Market Cap
$1.97 million
Optionable
Optionable
Beta
2.03

Social Links

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NASDAQ:XXII) was last updated on 4/16/2025 by MarketBeat.com Staff
From Our Partners